Redmile Group as of Sept. 30, 2021
Portfolio Holdings for Redmile Group
Redmile Group holds 75 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 13.4 | $768M | 13M | 59.27 | |
| Allakos | 3.9 | $226M | 2.1M | 105.87 | |
| Igm Biosciences (IGMS) | 3.9 | $225M | 3.4M | 65.76 | |
| Argenx Se Sponsored Adr (ARGX) | 3.8 | $221M | 731k | 302.00 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.6 | $205M | 7.5M | 27.16 | |
| Amicus Therapeutics (FOLD) | 3.5 | $199M | 21M | 9.55 | |
| The Beauty Health Company Com Cl A (SKIN) | 3.4 | $194M | 7.5M | 25.97 | |
| Livanova SHS (LIVN) | 3.0 | $174M | 2.2M | 79.19 | |
| Beam Therapeutics (BEAM) | 3.0 | $172M | 2.0M | 87.01 | |
| Celldex Therapeutics Com New (CLDX) | 2.9 | $164M | 3.0M | 53.99 | |
| Kymera Therapeutics (KYMR) | 2.9 | $164M | 2.8M | 58.74 | |
| Invitae (NVTAQ) | 2.6 | $151M | 5.3M | 28.43 | |
| Adagio Therapeutics (IVVD) | 2.4 | $137M | 3.2M | 42.24 | |
| Deciphera Pharmaceuticals | 2.4 | $137M | 4.0M | 33.98 | |
| Replimune Group (REPL) | 2.1 | $121M | 4.1M | 29.64 | |
| Atara Biotherapeutics | 2.0 | $116M | 6.5M | 17.90 | |
| Shattuck Labs (STTK) | 2.0 | $115M | 5.6M | 20.38 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.0 | $112M | 861k | 130.21 | |
| Krystal Biotech (KRYS) | 1.8 | $104M | 2.0M | 52.21 | |
| Seagen | 1.7 | $100M | 587k | 169.80 | |
| Absci Corp (ABSI) | 1.6 | $93M | 8.0M | 11.63 | |
| Nurix Therapeutics (NRIX) | 1.6 | $93M | 3.1M | 29.96 | |
| Verve Therapeutics (VERV) | 1.5 | $88M | 1.9M | 47.00 | |
| Scholar Rock Hldg Corp (SRRK) | 1.5 | $84M | 2.6M | 33.02 | |
| Regenxbio Inc equity us cm (RGNX) | 1.5 | $84M | 2.0M | 41.92 | |
| Oak Street Health | 1.4 | $80M | 1.9M | 42.53 | |
| Repare Therapeutics Ord (RPTX) | 1.2 | $67M | 2.6M | 26.24 | |
| Prothena Corp SHS (PRTA) | 1.1 | $64M | 902k | 71.23 | |
| Alx Oncology Hldgs (ALXO) | 1.1 | $64M | 864k | 73.86 | |
| Nevro (NVRO) | 1.1 | $63M | 543k | 116.38 | |
| Annexon (ANNX) | 1.1 | $62M | 3.3M | 18.61 | |
| Stoke Therapeutics (STOK) | 1.1 | $61M | 2.4M | 25.44 | |
| Akero Therapeutics (AKRO) | 1.0 | $60M | 2.7M | 22.35 | |
| Ngm Biopharmaceuticals | 0.9 | $53M | 2.5M | 21.02 | |
| Pliant Therapeutics (PLRX) | 0.9 | $52M | 3.1M | 16.88 | |
| ICU Medical, Incorporated (ICUI) | 0.9 | $52M | 223k | 233.38 | |
| Somalogic Class A Com | 0.9 | $49M | 4.0M | 12.39 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.9 | $49M | 1.1M | 43.70 | |
| Anthem (ELV) | 0.8 | $48M | 128k | 372.80 | |
| UnitedHealth (UNH) | 0.8 | $47M | 121k | 390.74 | |
| ImmunoGen | 0.8 | $47M | 8.3M | 5.67 | |
| Nuvation Bio Com Cl A (NUVB) | 0.8 | $45M | 4.5M | 9.94 | |
| Epizyme | 0.7 | $38M | 7.5M | 5.12 | |
| Medavail Holdings Ord | 0.6 | $34M | 12M | 2.92 | |
| Tcr2 Therapeutics Inc cs | 0.6 | $33M | 3.8M | 8.51 | |
| Gritstone Oncology Ord (GRTSQ) | 0.5 | $31M | 2.8M | 10.80 | |
| Stevanato Group S P A Ord Shs (STVN) | 0.5 | $30M | 1.2M | 25.31 | |
| Zymeworks | 0.4 | $26M | 882k | 29.04 | |
| Neoleukin Therapeutics | 0.4 | $25M | 3.5M | 7.23 | |
| Immatics SHS (IMTX) | 0.4 | $25M | 1.9M | 13.00 | |
| Avita Therapeutics (RCEL) | 0.4 | $24M | 1.3M | 17.72 | |
| Amedisys (AMED) | 0.4 | $22M | 150k | 149.10 | |
| Bioventus Com Cl A (BVS) | 0.4 | $21M | 1.5M | 14.16 | |
| Allovir (ALVR) | 0.4 | $21M | 837k | 25.06 | |
| Dynamics Special Purpose Cor Class A Com | 0.3 | $19M | 1.9M | 9.94 | |
| Alpha Teknova (TKNO) | 0.3 | $18M | 725k | 24.89 | |
| Lifestance Health Group (LFST) | 0.3 | $18M | 1.2M | 14.50 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.3 | $17M | 2.8M | 5.92 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $16M | 2.1M | 7.79 | |
| Zogenix Com New | 0.3 | $15M | 1.0M | 15.19 | |
| 1life Healthcare | 0.2 | $12M | 600k | 20.25 | |
| Profound Med Corp Com New (PROF) | 0.2 | $12M | 787k | 14.64 | |
| Hookipa Pharma Inc equity | 0.2 | $11M | 1.8M | 5.89 | |
| Stereotaxis Com New (STXS) | 0.2 | $10M | 1.9M | 5.38 | |
| Cytosorbents Corp Com New (CTSO) | 0.1 | $8.5M | 1.0M | 8.12 | |
| Cabaletta Bio (CABA) | 0.1 | $8.5M | 696k | 12.16 | |
| Itamar Med Sponsored Ads | 0.1 | $8.0M | 265k | 30.22 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $7.6M | 668k | 11.34 | |
| Atreca Cl A Com (BCEL) | 0.1 | $7.3M | 1.2M | 6.23 | |
| Aprea Therapeutics | 0.1 | $3.6M | 695k | 5.11 | |
| Xeris Pharmaceuticals | 0.1 | $3.3M | 1.4M | 2.45 | |
| Yumanity Therapeutics | 0.0 | $614k | 60k | 10.32 | |
| Tricida | 0.0 | $254k | 55k | 4.64 | |
| Syros Pharmaceuticals | 0.0 | $174k | 39k | 4.47 | |
| Ovid Therapeutics (OVID) | 0.0 | $137k | 41k | 3.37 |